📰 Aezs News
Page 6 - Aezs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aezs. Real-time updates on events, politics, business and more.
June 1, 2023
Equities research analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a note issued to investors on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “buy” rating and set a $28.00 price target on shares of Aeterna Zentaris in […]
June 1, 2023
Aeterna Zentaris Inc. (TSE:AEZS – Get Rating)’s share price rose 1.3% on Tuesday . The company traded as high as C$3.83 and last traded at C$3.83. Approximately 200 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 1,552 shares. The stock had previously closed at C$3.78. Aeterna Zentaris […]
May 31, 2023
Aeterna Zentaris Inc. (TSE:AEZS – Get Rating) shares shot up 1.3% during mid-day trading on Tuesday . The company traded as high as C$3.83 and last traded at C$3.83. 200 shares were traded during mid-day trading, a decline of 87% from the average session volume of 1,552 shares. The stock had previously closed at C$3.78. […]
May 26, 2023
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report released on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a research report on Tuesday, […]
May 25, 2023
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a research report on Tuesday, […]
May 18, 2023
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $28.00 price target on shares of Aeterna Zentaris in a research report […]
May 17, 2023
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research report on […]
May 14, 2023
Stock analysts at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $28.00 price target on shares of Aeterna Zentaris in […]
May 3, 2023
Aeterna Zentaris (NASDAQ:AEZS – Get Rating) and Addex Therapeutics (NASDAQ:ADXN – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Analyst Recommendations This is a summary of recent recommendations […]
May 2, 2023
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a report published on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a report on Tuesday, March 28th. […]